Immunotherapy in cancer treatment

Immunotherapy in cancer treatment

M532/0120 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 51.0MB

Downloadable file size: 4.5MB

Price image Pricing

Please login to use the price calculator


Caption: Immunotherapy in cancer treatment: use of a syringe to remove purified lymphocytes from a blood bag, prior to doping with Interleukin-2 (IL- 2). IL-2 is released naturally by certain key cells of the immune system (T-lymphocytes) after they have been activated by foreign antigens - of cancer cells, for instance. IL-2 amplifies the proliferation of other cell types, including lymphokine-activated killer (LAK) cells that attack cancer cells directly. Blood samples removed from a cancer victim are purified, the lymphocytes doped with IL-2 & cultured to boost the population of LAK cells. The product is then re-injected into the patient. Photographed at Centre Lyon Berard, Lyon, France, 1988/89.

Release details: Model release not required. Property release not required.

Keywords: apparatus, blood doping of, blood equipment, blood treatment, healthcare, immunotherapy, in immunotherapy, interleukin-2, lymphocyte, medical, medicine

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.